Использование макролидовпри леченииострого риносинусита
Использование макролидовпри леченииострого риносинусита
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Балмасова И.П., Еремина О.Ф., Гультяев М.М. и др. Иммунологические и аллергологические аспекты клинического применения макролидов. Рос. аллергологич. журн. 2007; 3: 12–9.
2. Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике. Смоленск: Русич, 1998.
3. Фещенко Ю.И. Макролиды. Доктор. 2000; 3: 56–60.
4. Фомина И.П. Современные макролиды, особенности действия, значение в лечении бактериальных инфекций. Антибиот. и химиотер. 1995; 4: 47–56.
5. Amsden GW. Anti-inflammatory effects of macrolides – an underappreciated benefit in the treatment of community -acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005; 55: 10–21.
6. Bosnar M, Kelneric Z, Munic V et al. Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin. Antimicrob Agents Chemother 2005; 49: 2372–7.
7. Craig WA, Gudmundson S. Postantibiotic effect. In: Antibiotic in Laboratory Medicine. Ed. Loran V. Baltimore, 1996: 403–1.
8. Culik O, Eracovic V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001; 429 (1–3): 209–29.
9.Gotfried MN. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004; 125: 52S–61S.
10. Labro MT. Cellular ffects of macrolides on leukocyte function. Curr pharm Des 2004; 10: 3067–80.
11. Lino Y, Sugita K, Toriyama M et al. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993; 119: 648–51.
12. MacLeod CM, Hamid QA, Cameron L et al. Antiinflammatory activity of clarythromycin in adult with chronically inflamed sinus mucosa. Adv Ther 2001; 18: 75–82.
13. Perloff JR, Gannon FH, Bolger WE. Bone involvement in sinusitis: An apparent pathway for the spread of disease. Laryngoscope 2000; 110 (12): 2095–9.
14. Rubin BK, Druce H, Ramires OE et al. Effect of Clarithromycin on nasal mucus properties in healthy sudjects and in patients with purulent rhinitis. Am J Respir Crit Care Med 1997; 155: 2018–23.
15. Suzuki H, Shimomura A, Ikeda K et al. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope 1997; 107: 1661–6.
2. Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике. Смоленск: Русич, 1998.
3. Фещенко Ю.И. Макролиды. Доктор. 2000; 3: 56–60.
4. Фомина И.П. Современные макролиды, особенности действия, значение в лечении бактериальных инфекций. Антибиот. и химиотер. 1995; 4: 47–56.
5. Amsden GW. Anti-inflammatory effects of macrolides – an underappreciated benefit in the treatment of community -acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005; 55: 10–21.
6. Bosnar M, Kelneric Z, Munic V et al. Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin. Antimicrob Agents Chemother 2005; 49: 2372–7.
7. Craig WA, Gudmundson S. Postantibiotic effect. In: Antibiotic in Laboratory Medicine. Ed. Loran V. Baltimore, 1996: 403–1.
8. Culik O, Eracovic V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001; 429 (1–3): 209–29.
9.Gotfried MN. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004; 125: 52S–61S.
10. Labro MT. Cellular ffects of macrolides on leukocyte function. Curr pharm Des 2004; 10: 3067–80.
11. Lino Y, Sugita K, Toriyama M et al. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993; 119: 648–51.
12. MacLeod CM, Hamid QA, Cameron L et al. Antiinflammatory activity of clarythromycin in adult with chronically inflamed sinus mucosa. Adv Ther 2001; 18: 75–82.
13. Perloff JR, Gannon FH, Bolger WE. Bone involvement in sinusitis: An apparent pathway for the spread of disease. Laryngoscope 2000; 110 (12): 2095–9.
14. Rubin BK, Druce H, Ramires OE et al. Effect of Clarithromycin on nasal mucus properties in healthy sudjects and in patients with purulent rhinitis. Am J Respir Crit Care Med 1997; 155: 2018–23.
15. Suzuki H, Shimomura A, Ikeda K et al. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope 1997; 107: 1661–6.
Авторы
А.С.Лопатин, А.В.Варвянская
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.